Actively Recruiting
Virtual Reality in End Stage Kidney Disease
Led by University of Pennsylvania · Updated on 2026-04-06
60
Participants Needed
1
Research Sites
17 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial to compare the social virtual reality and individual virtual reality in patients with end stage kidney disease who are hemodialysis. The main aim is to determine if there are differences in symptoms between the groups. Participants will use virtual reality glasses for 30-45 minutes during dialysis sessions for 4 weeks.
CONDITIONS
Official Title
Virtual Reality in End Stage Kidney Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of end stage kidney disease with hemodialysis 3 times per week for at least 1 month
You will not qualify if you...
- Acutely ill
- Active nausea
- Epilepsy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104
Actively Recruiting
Research Team
L
Lea Ann Matura, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here